Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
| Autor: | Giuseppe Lodi, Giovanni Cannarozzo, Mario Sannino, Markus Wied Dethlefsen, Michael Engelbrecht Nielsen, Steven Paul Nisticò |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Erythema Case Report Case Reports 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Fluorescent light medicine chromophore fluorescent light energy business.industry General Medicine medicine.disease Dermatology rosacea subtype 1 biophotonic platform inflammation Rosacea 030220 oncology & carcinogenesis and 3 medicine.symptom business erythema |
| Zdroj: | Clinical Case Reports |
| ISSN: | 2050-0904 |
| DOI: | 10.1002/ccr3.1891 |
| Popis: | Key Clinical Message Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|